PURCHASE OPTIONS

Contact one of our authorized distributors listed below to order DEXTENZA and receive it by the next business day.

Distributor Info
Phone
Fax
Website
ASD Healthcare
1-800-746-6273
1-800-547-9413
Besse Medical
1-800-543-2111
1-800-543-8695
Cardinal Specialty
Pharma Distribution
1-855-855-0708
1-614-553-6301
FFF Enterprises
1-800-843-7477
1-800-418-4333
Henry Schein Medical
1-800-772-4346
1-800-329-9109
Metro Medical
1-800-768-2002
1-615-256-4194
McKesson
Medical-Surgical
1-855-571-2100
1-800-311-3408
McKesson Plasma &
Biologics for Hospitals
1-877-625-2566
1-888-752-7626
McKesson
Specialty Health
1-855-477-9800
1-800-800-5673

Ocular Therapeutix does not recommend the use of any particular distributor.

Product
Ingredients
Size
NDC #
DEXTENZA
(dexamethasone ophthalmic insert) 0.4 mg
(dexamethasone USP)
1's
70382-204-01
DEXTENZA
(dexamethasone ophthalmic insert) 0.4 mg
(dexamethasone USP)
10's
70382-204-10

For further purchase inquiries, please contact your distributor or Ocular Therapeutix

Customer Service: 1-888-315-7906
Monday – Friday 9 AM – 3 PM ET


Billing and Coding

Codes needed to ensure proper billing for DEXTENZA

C-code: C9048

Additional codes needed to ensure proper billing for DEXTENZA

C-Code

C9048

Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
CPT Code

0356T

DEXTENZA Administration
NDC Number

70382-204-01,
70382-204-10

1-insert carton,
10-insert carton
CPT Modifiers

RT/LT

Right Eye/Left Eye
Misc. J-Codes

J3490, J3590

Unclassified drug, unclassified biologics

How a pass-through product is coded and billed1

  • Legislation established in 1999 allows Medicare beneficiaries and physicians access to new, innovative treatments2,3
  • CMS assigns every pass-through product a temporary C-code1
  • C-codes are reported and billed along with the appropriate CPT or HCPCS codes and are separately payable1
  • The C-code is most reliably reimbursed with Medicare Part B, the largest patient type for cataract surgery4

Some payers may prefer a J-code instead of a C-code. This depends on the payer and the site of care.


Visit DEXTENZA360.com

Committed to you and your patients

Providing Comprehensive Support

Benefits Investigation

A full report, including insurance coverage, within 2 business days.

Claims Assistance

Helping address your questions up front. Receive coding and billing guidance before a claim is submitted, assistance with monitoring claims, clearly communicated results, and payment details.

Prior Authorization (PA) Assistance

If a PA is necessary, we provide access to helpful forms and assistance with payer requirements to facilitate approval.

Appeal Assistance

Individualized guidance on appeal submission and assistance with documentation and forms. We track the status of appeals and clearly communicate results and next steps.

Financial Assistance Programs

Assistance for all qualifying patients. DEXTENZA360 will help determine patient eligibility and investigate options.

Making support convenient for you

Click

DEXTENZA360.com for 24/7 online access to interactive tools designed to help you throughout the access and reimbursement process.

Call

800-339-8369
(800-DEXTENZA) for your dedicated Case Manager
Monday—Friday 8:00 AM—8:00 PM ET (fax: 855-518-7564).

Connect

directly with your Ocular Therapeutix Field Reimbursement Manager or DEXTENZA360 Case Manager.

DEXTENZA360 provides comprehensive support for obtaining benefits verification and determining the appropriate codes preferred by the payer. Medicare Part B with a supplement is typically predictable regarding coverage and payment. For Medicare Advantage (Part C) or commercial patients, we recommend contacting your Ocular Therapeutix Field Reimbursement Manager or DEXTENZA360 beforehand.

References: 1. Centers for Medicare and Medicaid Services. Healthcare Common Procedure Coding System: Level II Coding Procedures. http://bit.ly/2TYBCCK. 2. HR Rep No. 106-436. pt 1 (1999). http://bit.ly/2p6WlBa. 3. Department of Health and Human Services. Medicare Program; Prospective Payment System for Hospital Outpatient Services: Final Rule. Fed Regist. 2000;65(68):18434-18820. http://bit.ly/2pyVNHH. 4. Market Research 2016-2018, ref. 00645. Ocular Therapeutix, Inc.

  open
  close
Full Prescribing Information
INDICATION

DEXTENZA is a corticosteroid indicated for the treatment of ocular inflammation and pain following ophthalmic surgery.

IMPORTANT SAFETY INFORMATION

Contraindications
DEXTENZA is contraindicated in patients with active corneal, conjunctival or canalicular infections, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella; mycobacterial infections; fungal diseases of the eye, and dacryocystitis.

Warnings and Precautions
Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. Steroids should be used with caution in the presence of glaucoma. Intraocular pressure should be monitored during treatment.

Corticosteroids may suppress the host response and thus increase the hazard for secondary ocular infections. In acute purulent conditions, steroids may mask infection and enhance existing infection.

Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex).

Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. Fungal culture should be taken when appropriate.

Use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation.

Adverse Reactions
The most common ocular adverse reactions that occurred in patients treated with DEXTENZA were: anterior chamber inflammation including iritis and iridocyclitis (10%); intraocular pressure increased (6%); visual acuity reduced (2%); cystoid macular edema (1%); corneal edema (1%); eye pain (1%) and conjunctival hyperemia (1%).

The most common non-ocular adverse reaction that occurred in patients treated with DEXTENZA was headache (1%).

Please see Full Prescribing Information.